within Pharmacolibrary.Drugs.ATC.L;

model L03AB07_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 0.0021666666666666666,
    adminDuration  = 600,
    adminMass      = 0.044,
    adminCount     = 1,
    Vd             = 0.00035,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Interferon beta-1a is a recombinant form of human interferon beta, used primarily in the treatment of relapsing forms of multiple sclerosis (MS). It is approved by regulatory agencies such as the FDA and EMA for MS to reduce frequency of relapses and slow progression of physical disability.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported for adult MS patients after subcutaneous administration of 44 micrograms three times a week.</p><h4>References</h4><ol><li><p>McKeage, K, &amp; Wagstaff, AJ (2007). Subcutaneous interferon-beta-1a : new formulation. <i>CNS drugs</i> 21(10) 871–876. DOI:<a href=&quot;https://doi.org/10.2165/00023210-200721100-00006&quot;>10.2165/00023210-200721100-00006</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17850174/&quot;>https://pubmed.ncbi.nlm.nih.gov/17850174</a></p></li><li><p>Zhao, Y, Mokliatchouk, O, Ramia, NF, Naylor, ML, &amp; Butts, CL (2022). Pharmacokinetics/pharmacodynamics by race: Analysis of a peginterferon β-1a phase 1 study. <i>Med (New York, N.Y.)</i> 3(9) 612–621.e3. DOI:<a href=&quot;https://doi.org/10.1016/j.medj.2022.06.006&quot;>10.1016/j.medj.2022.06.006</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35853458/&quot;>https://pubmed.ncbi.nlm.nih.gov/35853458</a></p></li><li><p>Freedman, MS, Wojcik, J, Holmberg, KH, Fluck, M, D&#x27;Antonio, M, Hyvert, Y, Stinchi, S, D&#x27;Urso, V, &amp; Dangond, F (2021). Pharmacodynamic biomarkers of long-term interferon beta-1a therapy in REFLEX and REFLEXION. <i>Journal of neuroimmunology</i> 360 577715–None. DOI:<a href=&quot;https://doi.org/10.1016/j.jneuroim.2021.577715&quot;>10.1016/j.jneuroim.2021.577715</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34536787/&quot;>https://pubmed.ncbi.nlm.nih.gov/34536787</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L03AB07_1;
